
S2-E63.3 – SurfingNASH’s 2021 NAFLD year-in-review Covers NASH Cost Effectiveness and Quality-of-Life
Jörn Schattenberg joins the Surfers to discuss the NASH cost-effectiveness research and related findings on quality of life.
Jörn Schattenberg joins the Surfers to discuss the NASH cost-effectiveness research and related findings on quality of life.
Fatty Liver Researcher and endocrinology key opinion leader Ken Cusi discusses the high levels of NAFLD prevalence and fibrosis among